Table of Contents

November 1, 2025; 39 (21-22)

Outlook

  • End of the line: a kinetic ruler model for poly(A) tail termination

    • Anita H. Corbett
    Genes Dev. November 1, 2025 39: 1267-1268; Published in Advance August 26, 2025, doi:10.1101/gad.353241.125
    OPEN ACCESS ARTICLE

    In this Outlook, Corbett discusses a study in this issue of Genes & Development by Gabs et al. that shows that competing reactions between the nuclear poly(A) binding protein 2 (NAB2) and the cleavage and polyadenylation complex (CPAC) kinetically control poly(A) tail length. Corbett explores the implications of this "kinetic ruler" model in advancing our understanding of post-transcriptional mRNA processing and gene regulation.

  • The two faces of MyoD: repressor and activator of gene expression during myogenesis

    • Carmen Birchmeier
    Genes Dev. November 1, 2025 39: 1269-1270; Published in Advance September 22, 2025, doi:10.1101/gad.353232.125
    OPEN ACCESS ARTICLE

    In this Outlook, Birchmeier discusses a study by Nicoletti et al. in this issue of Genes & Development that reports that MYOD unconventionally serves as a transcriptional repressor of nonmyogenic fates. Birchmeier highlights the duality of MYOD function as both an activator and a repressor of gene expression that together modulate the myogenic program during muscle development and regeneration.

Review

  • Multifaceted role of the vitamin B6 pathway in cancer: metabolism, immune interaction, and temporal and spatial regulation

    • Sushanta Kumar Mishra,
    • Bo Li,
    • Ana S.H. Costa,
    • Linda Van Aelst,
    • and Lingbo Zhang
    Genes Dev. November 1, 2025 39: 1271-1289; Published in Advance August 22, 2025, doi:10.1101/gad.352770.125

    In this review, Mishra et al. deconstruct the multifaceted role of vitamin B6 in cancer, functioning in a myriad of signaling and metabolic processes that support oncogenesis. They further contemplate the vitamin B6 pathway as a metabolic vulnerability in cancer cells and discuss emerging pharmacological interventions targeting it in a spatial and temporal context-dependent manner.

Research Communication

  • H3K4me3 amplifies transcription at intergenic active regulatory elements

    • Haoming Yu,
    • Yongyan Zhang,
    • Zhicong Liao,
    • Benjamin William Walters,
    • and Bluma J. Lesch
    Genes Dev. November 1, 2025 39: 1290-1298; Published in Advance August 18, 2025, doi:10.1101/gad.352841.125

    In this study, Yu et al. use systematic, targeted H3K4me3 deposition at intergenic cis-regulatory elements to elaborate on the genome-wide effect of H3K4me3 on transcription. The dynamic intergenic deposition of H3K4me3 promotes local transcription at permissive chromatin loci independent of enhancer function or target gene activity, suggesting that maintaining balanced H3K4me3 deposition supports transcriptional stability.

Research Papers

  • MYOD represses gene expression from non-E-box motifs

    • Chiara Nicoletti,
    • Jimmy Massenet,
    • Andreas P. Pintado-Urbanc,
    • Leah J. Connor,
    • Monica Nicolau,
    • Swetha Sundar,
    • Mingzhi Xu,
    • Anthony Schmitt,
    • Wenxin Zhang,
    • Zesen Fang,
    • Tsz Ching Indigo Chan,
    • Yu Xin Wang,
    • Stephen J. Tapscott,
    • Tom H. Cheung,
    • Matthew D. Simon,
    • Luca Caputo,
    • and Pier Lorenzo Puri
    Genes Dev. November 1, 2025 39: 1299-1317; Published in Advance August 6, 2025, doi:10.1101/gad.352708.125

    In this study, Nicoletti et al. report that MYOD serves as a transcriptional repressor during fibroblast trans-differentiation into skeletal muscle. Contrary to MYOD-activated gene expression, MYOD interacts with promoters and enhancers of the repressed genes by unconventional binding to non-E-box motifs, showcasing the genetic context-dependent complexity of MYOD's function during skeletal myogenesis.

  • A cell type-specific surveillance complex represses cryptic promoters during differentiation in an adult stem cell lineage

    • Neuza R. Matias,
    • Lorenzo Gallicchio,
    • Dan Lu,
    • Jongmin J. Kim,
    • Julian Perez,
    • Angela M. Detweiler,
    • Chenggang Lu,
    • Benjamin Bolival,
    • and Margaret T. Fuller
    Genes Dev. November 1, 2025 39: 1318-1337; Published in Advance August 6, 2025, doi:10.1101/gad.352747.125

    In this study, Matias et al. show that the zinc finger protein KMG and its binding partners fine-tune the transcriptional activity of spermatocyte-specific master regulator tMAC. Together, these factors counteract tMAC binding at weak or cryptic promoters and restrict aberrant transcription while permitting robust transcription from highly expressed tMAC/Aly-dependent promoters, reflecting a sophisticated cell type-specific surveillance system that functions during spermatocyte differentiation.

  • Mouse cortical cellular diversification through lineage progression of radial glia

    • Lin Yang,
    • Ziwu Wang,
    • Yanjing Gao,
    • Zhenmeiyu Li,
    • Guoping Liu,
    • Zhejun Xu,
    • Zhuangzhi Zhang,
    • Yan You,
    • Zhengang Yang,
    • and Xiaosu Li
    Genes Dev. November 1, 2025 39: 1338-1354; Published in Advance August 7, 2025, doi:10.1101/gad.352826.125

    In this study, Yang et al. characterize the cellular diversification and temporal dynamics of cortical radial glia lineage progression. Cortical progenitor trajectories were dictated by chromatin accessibility as well as stage-specific and cell type-specific transcription factor expression, which together control neurogenesis-to-gliogenesis transition in the cortex.

  • Dominant-negative effects of Weaver syndrome-associated EZH2 variants

    • Orla Deevy,
    • Jingjing Li,
    • Craig Monger,
    • Francesca Matrà,
    • Ellen Tuck,
    • Molly Davies,
    • Mihaly Badonyi,
    • Maeve Boyce,
    • Emma J. Doyle,
    • Karsten Hokamp,
    • Darragh Nimmo,
    • Simona Rodighiero,
    • Qi Zhang,
    • Chen Davidovich,
    • Joseph A. Marsh,
    • Diego Pasini,
    • Eric Conway,
    • and Adrian P. Bracken
    Genes Dev. November 1, 2025 39: 1355-1376; Published in Advance August 22, 2025, doi:10.1101/gad.351884.124

    In this study, Deevy et al. characterize EZH2 variants associated with the developmental disorder Weaver syndrome and identify a dominant-negative, non-loss-of-function mechanism at play that interferes with PRC2 activity. Contrary to EZH2 gain-of-function mutations that are associated with growth restriction, these EZH2 variants impair intergenic H3K27 methylation and chromatin compaction and cause selective cPRC1 eviction that together derepresses growth, highlighting the complexity of the Polycomb system in mammalian development.

  • A kinetic ruler controls mRNA poly(A) tail length

    • Emilie Gabs,
    • Emil Aalto-Setälä,
    • Aada Välisaari,
    • Anssi M. Malinen,
    • Torben Heick Jensen,
    • Stephen H. McLaughlin,
    • Lori A. Passmore,
    • and Matti Turtola
    Genes Dev. November 1, 2025 39: 1377-1394; Published in Advance August 22, 2025, doi:10.1101/gad.352912.125

    In this study, Gabs et al. show that poly(A) tail length is dictated by kinetic competition between poly(A) tail elongation mediated by the cleavage and polyadenylation complex and polyadenylation termination directed by the zinc finger poly(A) binding protein NAB2 in Saccharomyces. NAB2 dimerization and multidomain RNA binding are counterbalanced by the autoregulation of NAB2 protein concentration, which together fine-tune mRNA poly(A) tail synthesis and thus mRNA stability.

Corrigendum

  • Corrigendum: Ephrin-B2 controls PDGFRβ internalization and signaling

    • Akiko Nakayama,
    • Masanori Nakayama,
    • Christopher J. Turner,
    • Susanne Höing,
    • John J. Lepore,
    • and Ralf H. Adams
    Genes Dev. November 1, 2025 39: 1395; doi:10.1101/gad.353351.125
    OPEN ACCESS ARTICLE
« Previous

This Issue

November 1, 2025; 39 (21-22)
  1. Outlook
  2. Review
  3. Research Communication
  4. Research Papers
  5. Corrigendum

Find articles in this issue containing these words:

AltStyle によって変換されたページ (->オリジナル) /